Cargando…

Efficacy, quality of life, and acceptability outcomes of atypical antipsychotic augmentation treatment for treatment-resistant depression: protocol for a systematic review and network meta-analysis

BACKGROUND: Major depressive disorder (MDD) is a debilitating and costly mental disorder. Although commercially available antidepressants have proliferated over the last 20 years, a substantial number of patients either do not respond adequately to these drugs or are unable to tolerate their adverse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yiyun, Zhou, Xinyu, Qin, Bin, Del Giovane, Cinzia, Zhang, Yuqing, Xie, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234739/ https://www.ncbi.nlm.nih.gov/pubmed/25373601 http://dx.doi.org/10.1186/2046-4053-3-133

Ejemplares similares

Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis
por: Zhou, Xinyu, et al.
Publicado: (2015)

Systematic review of management for treatment-resistant depression in adolescents
por: Zhou, Xinyu, et al.
Publicado: (2014)

Comparative efficacy and acceptability of psychotherapies for acute anxiety disorders in children and adolescents: study protocol for a network meta-analysis
por: Zhang, Yuqing, et al.
Publicado: (2015)

Comparative efficacy and tolerability of first-generation and newer-generation antidepressant medications for depressive disorders in children and adolescents: study protocol for a systematic review and network meta-analysis
por: Zhou, Xinyu, et al.
Publicado: (2015)

New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression
por: Orzelska-Górka, Jolanta, et al.
Publicado: (2022)

Atypical antipsychotics as add-on treatment in late-life depression
por: Cakir, Sibel, et al.
Publicado: (2016)

Comparative efficacy and acceptability of antidepressants, psychological interventions, and their combination for depressive disorder in children and adolescents: protocol for a network meta-analysis
por: Zhou, Xinyu, et al.
Publicado: (2017)

Atypical Antipsychotics as Augmentation Therapy in Anorexia Nervosa
por: Marzola, Enrica, et al.
Publicado: (2015)

Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder
por: Wen, X.J., et al.
Publicado: (2014)

Dietary fiber and probiotics for the treatment of atypical antipsychotic-induced metabolic side effects: study protocol for a randomized, double-blind, placebo-controlled trial
por: Liu, Chenchen, et al.
Publicado: (2021)

T-RAC: Study protocol of a randomised clinical trial for assessing the acceptability and preliminary efficacy of adding an exergame-augmented dynamic imagery intervention to the behavioural activation treatment of depression
por: Tiba, Alexandru, et al.
Publicado: (2023)

Call to Caution with the Use of Atypical Antipsychotics for Treatment of Depression in Older Adults
por: Amodeo, Katherine, et al.
Publicado: (2016)

Nonalcoholic Fatty Liver Disease in Children and Adolescents Taking Atypical Antipsychotic Medications: Protocol for a Systematic Review and Meta-analysis
por: Hatem, Reem, et al.
Publicado: (2022)

Comparative efficacy and safety of 4 atypical antipsychotics augmentation treatment for major depressive disorder in adults: A systematic review and network meta-analysis
por: Wang, Jia, et al.
Publicado: (2023)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Comparative efficacy and tolerability of new-generation antidepressants for major depressive disorder in children and adolescents: protocol of an individual patient data meta-analysis
por: Zhou, Xinyu, et al.
Publicado: (2018)

Folate Augmentation of Treatment – Evaluation for Depression (FolATED): protocol of a randomised controlled trial
por: Roberts, Seren Haf, et al.
Publicado: (2007)

Atypical Antipsychotics and Other Therapeutic Options for Treatment of Resistant Major Depressive Disorder
por: Seo, Rubo J., et al.
Publicado: (2010)

Exercise enhances: study protocol of a randomized controlled trial on aerobic exercise as depression treatment augmentation
por: Schmitter, Michèle, et al.
Publicado: (2020)

Comparative efficacy and acceptability of psychotherapies for post-traumatic stress disorder in children and adolescents: study protocol for a systematic review and network meta-analysis
por: Zhang, Yuqing, et al.
Publicado: (2018)

Psychotherapy for depression in children and adolescents: study protocol for a systematic review and network meta-analysis
por: Qin, Bin, et al.
Publicado: (2015)

PROTOCOL: Treatment for depressive disorder among adults: An evidence and gap map of systematic reviews
por: Guo, Liping, et al.
Publicado: (2023)

Atypical antipsychotics in the treatment of early-onset schizophrenia
por: Hrdlicka, Michal, et al.
Publicado: (2015)

Antipsychotic augmentation in the treatment of obsessive-compulsive disorder
por: Thamby, Abel, et al.
Publicado: (2019)

Mortality risk of antipsychotic augmentation for adult depression
por: Gerhard, Tobias, et al.
Publicado: (2020)

Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo
por: Fourrier, Célia, et al.
Publicado: (2018)

Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis
por: Veale, David, et al.
Publicado: (2014)

Acceptability and proof of concept of internet-delivered treatment for depression, anxiety, and stress in university students: protocol for an open feasibility trial
por: Frazier, Patricia, et al.
Publicado: (2016)

Leukopenia and agranulocytosis in atypical antipsychotic treatment - besides clozapine
por: Jorge, B., et al.
Publicado: (2021)

Atypical Antipsychotics in the Treatment of Depressive and Psychotic Symptoms in Patients with Chronic Schizophrenia: A Naturalistic Study
por: Innamorati, Marco, et al.
Publicado: (2013)

Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium
por: Yoon, Hyung-Jun, et al.
Publicado: (2013)

Scopolamine augmentation of a newly initiated escitalopram treatment for major depressive disorder: study protocol for a randomized controlled trial
por: Zhou, Jingjing, et al.
Publicado: (2019)

Study protocol for the randomised controlled trial: Antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study)
por: McAllister-Williams, R Hamish, et al.
Publicado: (2013)

Adjunctive Atypical Antipsychotic Treatment for Major Depressive Disorder: A Meta-Analysis of Depression, Quality of Life, and Safety Outcomes
por: Spielmans, Glen I., et al.
Publicado: (2013)

Asenapine: an atypical antipsychotic with atypical formulations
por: Musselman, Meghan, et al.
Publicado: (2021)

PS78. Naturalistic, retrospective comparison between antidepressant therapy and atypical antipsychotic augmentation therapy for patients with major depressive disorder
por: Cho, Se Hoon, et al.
Publicado: (2016)

Study Protocol of an App-Based Prevention Program for Perinatal Depression
por: Tan, Xiangmin, et al.
Publicado: (2022)

Onset of action of atypical and typical antipsychotics in the treatment of acute psychosis
por: Mousavi, Seyed Ghafur, et al.
Publicado: (2013)

Atypical antipsychotics, more than just an antipsychotic
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2020)

Can Atypical Antipsychotic Augmentation Reduce Subsequent Treatment Failure More Effectively Among Depressed Patients with a Higher Degree of Treatment Resistance? A Meta-Analysis of Randomized Controlled Trials
por: Wang, Hee Ryung, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vug1ebrqi5tp7tinc8sirk7hpp